Health & Aging Brain Study: Health Disparities TAU Project

May 9, 2024 updated by: Sid E. O'Bryant

By doing this study we are trying to learn more about brain aging in Mexican Americans.

Participants will be asked to complete a screening visit to determine if it is safe to undergo a PET scan.

If eligible, participants will undergo a medical procedure that takes a picture of their brain. This procedure is called a PET scan of the brain.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Observational

Enrollment (Actual)

16

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • United States
    • Texas
      • Fort Worth, Texas, United States, 76107
        • University of North Texas Health Science Center Institute for Translational Research

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

Mexican Americans that participated in the Health & Aging Brain Study Amyloid Project

Description

Inclusion Criteria:

  • Participation in the Health & Aging Brain Study: Health Disparities Amyloid Project

Exclusion Criteria:

  • Not a participant in the Health & Aging Brain Study: Health Disparites Amyloid Project
  • Medical condition that precludes safe use of PET tracer

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Mexican American Adults
No intervention
Diagnostic test: PET scan of the brain with Flortaucipir
PET scan of the brain with non FDA approved Radio tracer.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Tau Accumulation Measured by PET Imaging
Time Frame: 4 weeks
Tau PET scan completed and radiologist reviewed imaging and provided a report on whether or not Tau protein was present in the brain.
4 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Sid E. O'Bryant

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 23, 2019

Primary Completion (Actual)

October 17, 2019

Study Completion (Actual)

April 20, 2021

Study Registration Dates

First Submitted

March 24, 2020

First Submitted That Met QC Criteria

March 26, 2020

First Posted (Actual)

March 27, 2020

Study Record Updates

Last Update Posted (Actual)

May 17, 2024

Last Update Submitted That Met QC Criteria

May 9, 2024

Last Verified

May 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • 2019-192

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

Yes

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Brain Aging in Mexican Americans

Clinical Trials on PET scan of the brain with Flortaucipir

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Benin

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe